Right of First Notice. If, during the period commencing on […***…] and ending on […***…] (“Notice Period”), Dimension elects for the first time to enter into discussions with a Third Party for rights to develop and Commercialize (or just to Commercialize) products arising out of its Hemophilia B Program in any country of the Territory, Dimension shall provide Bayer with […***…], and Bayer will have a period of […***…] in which to inform Dimension of its potential interest in negotiating for such rights (the “Expression of Interest Notice”). Dimension shall review any such Expression of Interest Notice […***…], and […***…]. Nothing in this Section 5.12.2 shall obligate Dimension or Bayer to enter into any license or other arrangement with respect to the Hemophilia B Program. For clarity, Dimension’s obligation to provide written notice to Bayer under this Section 5.12.2 shall only apply […***…].
Appears in 4 contracts
Samples: Collaboration and License Agreement (Ultragenyx Pharmaceutical Inc.), Collaboration and License Agreement (Dimension Therapeutics, Inc.), Collaboration and License Agreement (Dimension Therapeutics, Inc.)
